Ll-37 recalls
The FDA has published 2 recalls involving Ll-37 since 2020. The latest was reported on 27 Apr 2022. Most were for sterility. North American Custom Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing1latest 27 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why ll-37 is recalled
Companies
By year
Ongoing ll-37 recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | LL-37, 2000 MCG/ML vial, The Guyer Institute of Molecular recalled | Advanced Nutriceuticals | Sterility | 7 states |
All ll-37 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | LL-37 2 mg/mL Injection vials recalled by North American Custom | North American Custom Laboratories | Sterility | Nationwide |
| Drug | CLASS II | LL-37, 2000 MCG/ML vial, The Guyer Institute of Molecular recalled | Advanced Nutriceuticals | Sterility | 7 states |
Should you stop taking Ll-37?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.